Cited by 743Angiogenesis and VEGF in CancerBarrier Structure and Function StudiesLymphatic System and Diseases

Vascular Permeability Factor/Vascular Endothelial Growth Factor and the Significance of Microvascular Hyperpermeability in Angiogenesis

Dvorak, H. F., Nagy, J. A., Feng, D., Brown, L. F., Dvorak, A. M.·1999·Current Topics in Microbiology and Immunology

Abstract

This Chapter has reviewed the literature concerning VPF/VEGF as a potent vascular permeabilizing cytokine. In accord with this important role, microvessels have been found to be hyperpermeable to plasma proteins and other circulating macromolecules at sites where VPF/VEGF and its receptors are overexpressed, i.e., in tumors, healing wounds, retinopathies, many important inflammatory conditions and in certain physiological processes, such as ovulation and corpus luteum formation. Moreover, microvascular hyperpermeability to plasma proteins was shown to have an important consequence: the laying down of a fibrin-rich extracellular matrix. This provisional matrix, in turn, favors and supports the ingrowth of fibroblasts and endothelial cells which, together, transform the provisional matrix into the mature stroma characteristic of tumors and healed wounds. Finally, we have considered the pathways by which these and other circulating macromolecules cross the endothelium of normal and VPF/VEGF-permeabilized microvessels. These pathways include VVOs and trans-endothelial openings that have been variously interpreted as inter-endothelial cell gaps or trans-endothelial cell pores. At least some trans-endothelial cell pores may arise from VVOs. In conclusion, these data provide new insights into the mechanisms of angiogenesis and stroma formation, insights which are potentially applicable to a wide variety of disease states and which may lead to identification of new targets for therap…

Integrity signals

Registry

Crossref · 10.1007/978-3-642-59953-8_6

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • VEGF can contribute to systemic intravasation by increasing microvascular permeability.

    “VEGF can also contribute to systemic intravasation by increasing microvascular permeability (Claffey et al., 1996;Dvorak et al., 1999).”

    From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Dvorak et al., 1999

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 175 · Cited by 743

Authors
Dvorak, H. F., Nagy, J. A., Feng, D., Brown, L. F., & Dvorak, A. M.
Affiliations
Beth Israel Deaconess Medical Center (US)
Venue
Current Topics in Microbiology and Immunology
Published
1999
Volume
237
Pages
97-132
ISSN
0070-217X (ISSN-L)
OpenAlex
W189480869
Cited by
743
References
175
Citations by year
2026: 2 · 2025: 7 · 2024: 9 · 2023: 9 · 2022: 21 · 2021: 15 · 2020: 18 · 2019: 20 · 2018: 17 · 2017: 12 · 2016: 16 · 2015: 21 · 2014: 16 · 2013: 39 · 2012: 23
FWCI
46.96
Type
book chapter
Language
en
Open access
closed
Locations
  • Current topics in microbiology and immunology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
Keywords
vascular endothelial growth factor, microvascular hyperpermeability, angiogenesis, plasma protein leakage, wound healing, retinopathy, vascular occlusion, ovulation, corpus luteum formation, inflammatory diseases
MeSH terms
Animals, Capillary Permeability, Endothelium, Vascular, Humans, Lymphokines, Microscopy, Electron, Neoplasms, Neovascularization, Pathologic, Venules, Endothelial Growth Factors, Receptors, Growth Factor, Neovascularization, Physiologic, Receptor Protein-Tyrosine Kinases, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review